Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -98,333 | -66,394 | -59,277 |
| Depreciation Amortization | 304 | 271 | 120 |
| Accounts payable and accrued liabilities | 2,378 | -180 | -426 |
| Other Working Capital | 2,729 | 1,482 | 1,791 |
| Other Operating Activity | 11,771 | 5,325 | 3,232 |
| Operating Cash Flow | $-81,151 | $-59,496 | $-54,560 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -481 | -115 | -672 |
| Purchase Of Investment | -93,596 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -50 | -229 |
| Other Investing Activity | 0 | -50 | -229 |
| Investing Cash Flow | $-94,077 | $-165 | $-901 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 4,000 | N/A |
| Debt Repayment | -410 | -425 | -163 |
| Common Stock Issued | 89,203 | 100,302 | 332 |
| Common Stock Repurchased | -17 | N/A | N/A |
| Other Financing Activity | 0 | -86 | 20 |
| Financing Cash Flow | $88,776 | $103,791 | $189 |
| Beginning Cash Position | 124,718 | 80,588 | 135,860 |
| End Cash Position | 38,266 | 124,718 | 80,588 |
| Net Cash Flow | $-86,452 | $44,130 | $-55,272 |
| Free Cash Flow | |||
| Operating Cash Flow | -81,151 | -59,496 | -54,560 |
| Capital Expenditure | -481 | -115 | -672 |
| Free Cash Flow | -81,632 | -59,611 | -55,232 |